RA Capital Management, L.P. 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-15 5:12 pm Sale |
2022-08-15 | 13G | KalVista Pharmaceuticals, Inc. KALV |
RA Capital Management, L.P. | 0 0.000% |
-1,930,322 (Position Closed) |
Filing |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
RA Capital Management, L.P. | 1,930,322 7.900% |
530,833 (+37.93%) |
Filing |
| 2021-05-27 4:44 pm Purchase |
2021-05-24 | 13G | KalVista Pharmaceuticals, Inc. KALV |
RA Capital Management, L.P. | 1,399,489 5.700% |
613,219 (+77.99%) |
Filing |